| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 17, 2004
From the Departments of Molecular and Cellular Physiology (M.I., T.V., K.Y.S., T.V.A., G.Y., D.N.G.) and Neurosurgery (A.N.), Louisiana State University Health Sciences Center, Shreveport, La. * To whom correspondence should be addressed. E-mail: dgrang{at}lsuhsc.edu.
Background--CD40/CD40 ligand (CD40L) signaling contributes to proinflammatory and prothrombogenic responses in the vasculature. CD40/CD40L expression is elevated in patients after a transient ischemic attack or stroke. The purpose of this study was to investigate the role of CD40/CD40L signaling in cerebral microvascular dysfunction and tissue injury response to middle cerebral artery occlusion (MCAO) and reperfusion. Methods and Results--Intravital fluorescence microscopy was used to visualize the cerebral microcirculation of wild-type (WT), CD40-deficient, and CD40L-deficient mice subjected to 1-hour MCAO and 4-hour reperfusion. The adhesion of platelets and of leukocytes and vascular permeability were measured in postcapillary venules after 4-hour and 1-hour reperfusions, respectively. Cerebral infarct volume was analyzed 24 hours after reperfusion. Platelet and leukocyte adhesion was elevated and blood/brain barrier function was compromised by MCAO in WT mice. Blood cell recruitment and increased permeability were blunted in both CD40-deficient and CD40L-deficient mice. Infarct volume was also reduced in CD40- and CD40L-deficient mice compared with WT mice. Conclusions--Our findings indicate that CD40/CD40L signaling contributes to inflammatory and prothrombogenic responses and brain infarction induced by MCAO and reperfusion. The CD40/CD40L dyad may play a significant pathogenic role in the acute phase of ischemic stroke.
Revised on November 18, 2004
Accepted on November 23, 2004
CD40/CD40 Ligand Signaling in Mouse Cerebral Microvasculature After Focal Ischemia/Reperfusion
Mami Ishikawa MD, PhD,
Related Article:
Circulation 2005 111: 1567.
This article has been cited by other articles:
![]() |
D. J Stott, P. Welsh, A. Rumley, M. Robertson, I. Ford, N. Sattar, R. G J Westendorp, J W. Jukema, S. M Cobbe, and G. D O Lowe Adipocytokines and risk of stroke in older people: a nested case-control study Int. J. Epidemiol., February 1, 2009; 38(1): 253 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-A. C. Portillo, J. Van Grol, L. Zheng, G. Okenka, K. Gentil, A. Garland, E. C. Carlson, T. S. Kern, and C. S. Subauste CD40 Mediates Retinal Inflammation and Neurovascular Degeneration J. Immunol., December 15, 2008; 181(12): 8719 - 8726. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Klohs, M. Grafe, K. Graf, J. Steinbrink, T. Dietrich, D. Stibenz, P. Bahmani, G. Kronenberg, C. Harms, M. Endres, et al. In Vivo Imaging of the Inflammatory Receptor CD40 After Cerebral Ischemia Using a Fluorescent Antibody Stroke, October 1, 2008; 39(10): 2845 - 2852. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Terao, G. Yilmaz, K. Y. Stokes, J. Russell, M. Ishikawa, T. Kawase, and D. N. Granger Blood Cell-Derived RANTES Mediates Cerebral Microvascular Dysfunction, Inflammation, and Tissue Injury After Focal Ischemia-Reperfusion Stroke, September 1, 2008; 39(9): 2560 - 2570. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Terao, G. Yilmaz, K. Y. Stokes, M. Ishikawa, T. Kawase, and D. N. Granger Inflammatory and Injury Responses to Ischemic Stroke in Obese Mice Stroke, March 1, 2008; 39(3): 943 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
Hardev Ramandeep Singh Girn, S. Ahilathirunayagam, A. I. D. Mavor, and S. Homer-Vanniasinkam Reperfusion Syndrome: Cellular Mechanisms of Microvascular Dysfunction and Potential Therapeutic Strategies Vascular and Endovascular Surgery, September 1, 2007; 41(4): 277 - 293. [Abstract] [PDF] |
||||
![]() |
F. N. E. Gavins, J. Dalli, R. J. Flower, D. N. Granger, and M. Perretti Activation of the annexin 1 counter-regulatory circuit affords protection in the mouse brain microcirculation FASEB J, June 1, 2007; 21(8): 1751 - 1758. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ishikawa, E. Sekizuka, N. Yamaguchi, H. Nakadate, S. Terao, D. N. Granger, and H. Minamitani Angiotensin II type 1 receptor signaling contributes to platelet-leukocyte-endothelial cell interactions in the cerebral microvasculature Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2306 - H2315. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Lister and M. J. Hickey Immune complexes alter cerebral microvessel permeability: roles of complement and leukocyte adhesion Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H694 - H704. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chamorro and J. Hallenbeck The Harms and Benefits of Inflammatory and Immune Responses in Vascular Disease Stroke, February 1, 2006; 37(2): 291 - 293. [Full Text] [PDF] |
||||
![]() |
T. Vowinkel, K. C. Wood, K. Y. Stokes, J. Russell, C. F. Krieglstein, and D. N. Granger Differential expression and regulation of murine CD40 in regional vascular beds Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H631 - H639. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |